Survival analysis and end-points:
The primary end-point of our study was a composite end-point of major cardiovascular events comprising left ventricular assisted device implantation, heart transplantation, and all-cause mortality. LV systolic function recovery is defined as improving LVEF>10% and increasing over 40%. A total of 37 patients were included in the study.